PRISM Inserm 01192
A research
![]( "hero-step1")
Committed to techological
A research
laboratory
Committed to techological
& therapeutical progress
An interdisciplinary laboratory integrating biologists, molecular biologists, biochemists, clinician, chemists and physicians.
PRISM Laboratory is part of the Biology Department of Faculty of Sciences and Technologies at University of Lille (ULille).
Historically located on the 1st floor of the SN3 building at the campus Cité Scientifique of the University of Lille, since 2013 PRISM is also partially located at the Faculty of Medicine of University of Lille at the hospital campus at the the Regional Cancer Comprehensive Center of Lille, Centre Oscar Lambret (COL) and recently at the Institute of Cancer Research of Lille (2023) for translational researches.
Solutions
See more
Our Research Focus Areas
The laboratory is organized as a single-team unit around two main axes, the first one being devoted to Technological Innovations and the second to Therapeutic Innovations. PRISM is co-directed by Pr. M. Salzet and Pr. I. Fournier.
- Technological innovation
Cosmix (eary diagnosis)
New technologies and diagnostic methods based on the molecular characterisation of cells
- Technological innovation
NEXTGENESIS (therapy)
New technologies for surgery and surgeons assistance
- Therapeutic Innovation
Tumor Microenvironment (early diagnosis)
Tumour’s microenvironment analysis for cancer cells profiling and targeted therapies.
- Therapeutic Innovation
Immunotherapy (therapy)
Treatments, immunological and cell therapy
Partnering
More about our platform offers
Driving Innovation for All
PRISM also offers its expertise in proteomics, mass spectrometry imaging and 3D cell modelling to other laboratories and private companies via the ORGANOMICS platform.
The ORGANOMICS platform offers advanced expertise in proteomics, mass spectrometry imaging, and the creation of 3D cellular models. It specializes in non-targeted proteomics, interactomics, and spatial proteomics, particularly for FFPE tissue analysis, as well as exosome analysis. The platform also excels in creating 3D cellular models (spheroids, organoids, bioprinting) to simulate pathological contexts and test treatments.
For access to these services, please contact our team to discuss your project.
Blog
